SAN DIEGO--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today ...
Newron Pharmaceuticals SpA is taking over NeuroNova AB in a stock-based deal valued at €15.4 million (US$19.4 million), which will add two clinical-stage programs to its pipeline of drugs for ...
Newron Pharmaceuticals SpA’s proposed acquisition of NeuroNova AB is too expensive and may derail the introduction of Newron’s most promising drug, according to the company’s largest shareholder. The ...
SAN DIEGO--(BUSINESS WIRE)--$CLDI #immunotherapy--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company ...
Company to also share progress with cell-based virotherapy platforms for advanced solid tumors “Our cell-based virotherapeutics are designed to target tumors directly and to help the immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results